IRulya Therapeutics, Inc. (IRLA)
32.95
+1.33
(+4.21%)
USD |
NASDAQ |
Oct 30, 16:00
33.50
+0.55
(+1.67%)
After-Hours: 20:00
IRulya Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| June 29, 2026 | 0.81 |
| June 26, 2026 | 0.8302 |
| June 25, 2026 | 0.8589 |
| June 24, 2026 | 0.8374 |
| June 23, 2026 | 0.8519 |
| June 22, 2026 | 0.8162 |
| June 18, 2026 | 0.8316 |
| June 17, 2026 | 0.7946 |
| June 16, 2026 | 0.7922 |
| June 15, 2026 | 0.8192 |
| June 12, 2026 | 0.8216 |
| June 11, 2026 | 0.8333 |
| June 10, 2026 | 0.8007 |
| June 09, 2026 | 0.8535 |
| June 08, 2026 | 0.8799 |
| June 05, 2026 | 0.8887 |
| June 04, 2026 | 0.9679 |
| June 03, 2026 | 0.9063 |
| June 02, 2026 | 0.9239 |
| June 01, 2026 | 0.9767 |
| May 29, 2026 | 1.012 |
| May 28, 2026 | 1.030 |
| May 27, 2026 | 1.012 |
| May 26, 2026 | 1.056 |
| May 22, 2026 | 0.9679 |
| Date | Value |
|---|---|
| May 21, 2026 | 0.9415 |
| May 20, 2026 | 0.9503 |
| May 19, 2026 | 0.9415 |
| May 18, 2026 | 0.8753 |
| May 15, 2026 | 1.012 |
| May 14, 2026 | 1.038 |
| May 13, 2026 | 1.074 |
| May 12, 2026 | 1.109 |
| May 11, 2026 | 1.091 |
| May 08, 2026 | 1.126 |
| May 07, 2026 | 1.144 |
| May 06, 2026 | 1.074 |
| May 05, 2026 | 1.082 |
| May 04, 2026 | 1.074 |
| May 01, 2026 | 1.170 |
| April 30, 2026 | 1.153 |
| April 29, 2026 | 1.082 |
| April 28, 2026 | 1.082 |
| April 27, 2026 | 1.135 |
| April 24, 2026 | 1.197 |
| April 23, 2026 | 1.197 |
| April 22, 2026 | 1.206 |
| April 21, 2026 | 1.179 |
| April 20, 2026 | 1.118 |
| April 17, 2026 | 1.206 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Korsana Biosciences, Inc. | 3.602 |
| PepGen Inc. | 1.367 |
| Q32 Bio, Inc. | 1.997 |
| Bridgebio Oncology Therapeutics, Inc. | 0.6496 |
| Arrowhead Pharmaceuticals, Inc. | 18.16 |
Price to Book Value Related Metrics
| Price | 32.95 |
| Earnings Yield | -381.2% |
| Market Cap | 33.51M |